Trastuzumab (T) plus oral vinorelbine (OV) in patients with advanced breast cancer (ABC) overexpressing Her2/neu

被引：0
|
作者：
不详
机构：
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：168 / 168
页数：1
相关论文
共 50 条
  • [1] Is the combination of trastuzumab and vinorelbine an active regimen in metastatic breast cancer patients overexpressing HER2/neu?
    Czerniawska, M
    Jagiello-Gruszfeld, AI
    Zbrzezniak, J
    Wachula, E
    Kazarnowicz, A
    Sikorska, M
    Szablowska-Siwik, S
    Ziomek, M
    Gugala, K
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 277 - 277
  • [2] Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer
    Bergen, Elisabeth
    Berghoff, Anna S.
    Rudas, Margaretha
    Dubsky, Peter
    De Vries, Catharina
    Sattlberger, Claudia
    Mader, Robert M.
    Zagouri, Flora
    Sparber, Cornelia
    Fitzal, Florian
    Gnant, Michael
    Rottenfusser, Andrea
    Zielinski, Christoph C.
    Preusser, Matthias
    Steger, Guenther G.
    Bartsch, Rupert
    [J]. BREAST CARE, 2014, 9 (05) : 344 - 348
  • [3] TRASTUZUMAB (T) AND VINORELBINE (V) FOR PATIENTS (PTS) WITH HER2-OVEREXPRESSING ADVANCED BREAST CANCER (ABC). A PILOT PHASE II STUDY
    Ferrau', Francesco
    Adamo, Vincenzo
    Bordonaro, Roberto
    Caristi, Nicola
    Colina, Paolo
    D'Angelo, Alessandro
    Garipoli, Claudia
    Lavenia, Giuseppe
    Priolo, Domenico
    Rossello, Rosalba
    Tralongo, Paolo
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 25 - 25
  • [4] Trastuzumab plus gemcitabine and cisplatin chemotherapy for HER2/neu-overexpressing breast cancer with visceral metastasis
    Elsaid, A. A.
    Elkerm, Y.
    El-Shami, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu
    Santin, Alessandro D.
    Bellone, Stefania
    Roman, Juan J.
    McKenney, Jesse K.
    Pecorelli, Sergio
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 102 (02) : 128 - 131
  • [6] Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2
    E Brain
    N Isambert
    F Dalenc
    V Diéras
    J Bonneterre
    K Rezai
    M Jimenez
    F Mefti-Lacheraf
    E Cottura
    P Tresca
    L Vanlemmens
    C Mahier-Aït Oukhatar
    F Lokiec
    P Fumoleau
    [J]. British Journal of Cancer, 2012, 106 : 673 - 677
  • [7] Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2
    Brain, E.
    Isambert, N.
    Dalenc, F.
    Dieras, V.
    Bonneterre, J.
    Rezai, K.
    Jimenez, M.
    Mefti-Lacheraf, F.
    Cottura, E.
    Tresca, P.
    Vanlemmens, L.
    Oukhatar, C. Mahier-Ait
    Lokiec, F.
    Fumoleau, P.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (04) : 673 - 677
  • [8] Phase II Study of Vinorelbine Plus Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes
    Lee, Yu Rim
    Huh, Seok Jae
    Lee, Dong Hyun
    Yoon, Hyun Hwa
    Seol, Young-Mi
    Choi, Young-Jin
    Kwon, Kyung A.
    Lee, Suee
    Oh, Sung Yong
    Kim, Sung-Hyun
    Kim, Hyo-Jin
    Kwon, Hyuk-Chan
    [J]. JOURNAL OF BREAST CANCER, 2011, 14 (02) : 140 - 146
  • [9] Trastuzumab (T) plus vinorelbine (VNR) as first combination in Her-2 overexpressing patients with metastatic breast cancer.
    Glogowska, I
    Sienkiewicz-Kozlowska, R
    Bauer-Kosinska, B
    Jaczewska, S
    Pienkowski, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 235S - 235S
  • [10] Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: The trastuzumab and vinorelbine or taxane study
    Burstein, Harold J.
    Keshaviah, Aparna
    Baron, Ari D.
    Hart, Ronald D.
    Lambert-Falls, Rosemary
    Marcom, P. Kelly
    Gelman, Rebecca
    Winer, Eric P.
    [J]. CANCER, 2007, 110 (05) : 965 - 972
12345